Endogenex™ Appoints Krissy Wright as Chief Financial Officer

Bringing finance, operational, and corporate development expertise to an experienced leadership team.…

ZTE, Nokia, and Huawei Lead ABI Research's 5G FWA CPE Vendor Competitive Ranking

LONDON, Jan. 14, 2025 /PRNewswire/ — A new Competitive Ranking by global…

Argon Medical Expands Oncology Product Offering with Acquisition of the SeQure® and DraKon™ Microcatheters

PLANO, Texas, Jan. 14, 2025 /PRNewswire/ — Argon Medical, a leading provider…

RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor, Engineered for…

Cognex Strengthens Market Leadership in Industrial Barcode Reading with Two New AI-Powered Products

DataMan 290 and 390 barcode readers, backed by industry-leading customer support, deliver…

IFF Pharma Solutions Wins Pharmaceutical Technology Excellence Award

Recognized for brand leadership with its "Timing is Everything" controlled release platform…

Korea's Leading Indie Beauty Brand d'Alba, Reaches New Heights Globally with 210% Overseas Sales Surge

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — Premium vegan beauty brand d’Alba…

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — ImmunoForge announced that it…